KA
CDMO

Kerrisdale Advisers’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Kerrisdale Advisers’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-62,306
Closed -$445K – 105
2024
Q2 		$445K Hold
62,306
– – 0.14% 78
2024
Q1 		$417K Sell
62,306
-6,250
-9% -$43K 0.13% 74
2023
Q4 		$446K Buy
68,556
+19,526
+40% +$126K 0.13% 72
2023
Q3 		$463K Buy
+49,030
New +$590K 0.15% 74

Other funds holding CDMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
AC
AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAIM
Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return

Kerrisdale Advisers's CDMO Position: Q3 2024 in Review

Kerrisdale Advisers sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q3 2024, closing a stake of 62,306 shares — an estimated $445K sold.

Kerrisdale Advisers first reported a position in CDMO in Q3 2023 and held it in 4 quarters. The position peaked at $463K in Q3 2023. 171 funds tracked by Wall St. Rank hold CDMO as of Q3 2024.

  • Kerrisdale Advisers reported no remaining Avid Bioservices, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Kerrisdale Advisers sold 62,306 Avid Bioservices, Inc. Common Stock shares in Q3 2024, an estimated $445K.
  • Kerrisdale Advisers first reported a position in Avid Bioservices, Inc. Common Stock in Q3 2023 and held it in 4 quarters.
  • Kerrisdale Advisers's Avid Bioservices, Inc. Common Stock position peaked at $463K in Q3 2023.
  • 171 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q3 2024.

Based on Kerrisdale Advisers's 13F filing for Q3 2024, filed 14 Nov 2024.